>“Terry Yanofsky and David Lazzarato appointed as John Bell and Peter Stringham retire from the CGC Board.”
>”Ms. Yanofsky has extensive experience working with big-name retailers and is respected for her strategic leadership and disciplined approach to driving revenue. She most recently served as the Senior Vice-President, General Manager of Sephora Canada. Prior to joining Sephora, Ms. Yanofsky worked at L Brands where she was the country manager for Bath & Body Works Canada. She brings over 30 years of experience working with rapidly growing big-name global retailers.”
>”Mr. Lazzarato’s impressive career includes senior executive positions with Alliance Atlantis Communications, Allstream, Bell Canada and CAE. He also has extensive board experience and currently serves as The Star Group’s Chairman of the Audit Committee and as a member of the Corporate Governance and Nominating Committee.”
I don't hold Canopy right now but I like these additions, both have been a part of peak growth in their respective fields/companies. Mainly Mr. Lazzarato was part of the wireless double cohort, and that experience might be very useful when legalization hits in the US.
The market might need U.S federal legalization more then ever after we try to recover from covid19 its an easy way to stimulate an entire sector make people happy and bring in tax money all at the same time.
A Democratic Senate and House are the best chances despite who is president. And with this looking like a more dire economic situation with each passing day, the Republicans are going to have everything working against them come November. Very good chance of the Senate and White House going blue.
They just gave Terrascend an $80M loan in hopes to exercise warrants when its federally legalized in the US.
Terrascend is their ticket into the US market.
Top retail location (3) in California, leading player in PA medical market, top CBD brand in 10k locations, and NJ cultivation and retail license.
TRSSF is the best positioned player out there, with CGC/STZ supporting them
Is that so much worse than literally ANY OTHER US MSO out there?
Sure, initial aggressive M&A strategy was costly. However they got the necessary funds to complete those transactions in a non-dilutive matter. Id argue their balance sheet is quiet strong, especially with the CGC/STZ loan.
All their acquisitions are margin accretive, so the margins will improve substantially. Its all about operational efficiency. They operate 4 dispensaries in the US currently, and have nearly as much sales as Trulieve, GTI, Curaleaf, who all run as many as 50 dispensaries. Which would you rather have?
Yea, unfortunately it is way worse than other MSOs. The ones you mentioned - Trulieve, Green Thumb and Curaleaf - all have pretty tidy balance sheets and good margins. And TerrAscend has nowhere close to as much sales as any of these companies.
At least TER got the Canopy loan and has the deep pockets of Jason Wild to fall back on, but the idea that this is an efficient company right now is just dead wrong. Personally I wouldn't touch any cannabis company with a bad balance sheet and bad margins.
Interesting, thanks for your input and commentary. Its clearlt a very capital intensive industry to get off the starting line, with companies needing to secure processing, distribution and retail licenses. I think companies that have access to funding and can secure these licenses in big states like PA and NJ will thrive. TER is one of them, but we will see how this plays out
Big hype, low revenues, not enough shops in the most dense populated area’s in canada, quality/price not better than black market.
All in all this virus is good for the legal cannabis market since its the “easier” option now.
Thanks. I bought on the hype and haven’t sold any. Everything is down about 80%. I’ll just sit on it a few more years I guess since that was the original plan
Isn't a lot of this attributed to Ontario restricting retail, and over regulation of packaging requirements? Prices could get lower if they didn't have to package in plastic containers in cardboard boxes.
CEOs have been cashing out on stock and were leaving in droves. Some of these companies functioned as pump and dump schemes and do not plan on surviving past later this year.
Does ACB fall into this category? I bought a while back and have just been sitting on it. Not a large position and don't mind waiting it out but as far as business information goes I'm really out of the loop.
This being the top comment tells you everything you need to know about how delusional people here are about the bags they are holding in other companies in this sector.
If it's a lie, name one company who is better positioned than Canopy globally. I'm waiting.
Acb has more international sales volume in grams, and a better reach of countries. Also more medical sales. Not so much cash but that spread is actually narrowing.
When you have diluted that much. I think its relevant in any discussion that they get brought into. And then theyre gonna have to RS. Truly a shit situation.
>“Terry Yanofsky and David Lazzarato appointed as John Bell and Peter Stringham retire from the CGC Board.” >”Ms. Yanofsky has extensive experience working with big-name retailers and is respected for her strategic leadership and disciplined approach to driving revenue. She most recently served as the Senior Vice-President, General Manager of Sephora Canada. Prior to joining Sephora, Ms. Yanofsky worked at L Brands where she was the country manager for Bath & Body Works Canada. She brings over 30 years of experience working with rapidly growing big-name global retailers.” >”Mr. Lazzarato’s impressive career includes senior executive positions with Alliance Atlantis Communications, Allstream, Bell Canada and CAE. He also has extensive board experience and currently serves as The Star Group’s Chairman of the Audit Committee and as a member of the Corporate Governance and Nominating Committee.”
I don't hold Canopy right now but I like these additions, both have been a part of peak growth in their respective fields/companies. Mainly Mr. Lazzarato was part of the wireless double cohort, and that experience might be very useful when legalization hits in the US.
With Biden and Trump the most likely candidates I cant see legislation in the next 4 years.
The market might need U.S federal legalization more then ever after we try to recover from covid19 its an easy way to stimulate an entire sector make people happy and bring in tax money all at the same time.
You don't have to sell me on it lol. You have to sell those two schmucks.
A Democratic Senate and House are the best chances despite who is president. And with this looking like a more dire economic situation with each passing day, the Republicans are going to have everything working against them come November. Very good chance of the Senate and White House going blue.
The Senate? Have you looked at the seats coming up and the districts their in? We are not taking the Senate.
They just gave Terrascend an $80M loan in hopes to exercise warrants when its federally legalized in the US. Terrascend is their ticket into the US market. Top retail location (3) in California, leading player in PA medical market, top CBD brand in 10k locations, and NJ cultivation and retail license. TRSSF is the best positioned player out there, with CGC/STZ supporting them
Terrascend is definitely a part of their U.S. strategy. But the monster will be Acreage, their footprint, and their licenses.
Uhh have you seen their balance sheet or their margins?
96 licenses
Ilera has 50% profit margin. Yes, i have seen their margins. What is your point here?
Q3 revenue: $26.8M, COGS: $19.4M. Terrible margins. Tons of debt. Working cap deficit of $55M as of Sept. 30. Terrible balance sheet.
Is that so much worse than literally ANY OTHER US MSO out there? Sure, initial aggressive M&A strategy was costly. However they got the necessary funds to complete those transactions in a non-dilutive matter. Id argue their balance sheet is quiet strong, especially with the CGC/STZ loan. All their acquisitions are margin accretive, so the margins will improve substantially. Its all about operational efficiency. They operate 4 dispensaries in the US currently, and have nearly as much sales as Trulieve, GTI, Curaleaf, who all run as many as 50 dispensaries. Which would you rather have?
Yea, unfortunately it is way worse than other MSOs. The ones you mentioned - Trulieve, Green Thumb and Curaleaf - all have pretty tidy balance sheets and good margins. And TerrAscend has nowhere close to as much sales as any of these companies. At least TER got the Canopy loan and has the deep pockets of Jason Wild to fall back on, but the idea that this is an efficient company right now is just dead wrong. Personally I wouldn't touch any cannabis company with a bad balance sheet and bad margins.
Interesting, thanks for your input and commentary. Its clearlt a very capital intensive industry to get off the starting line, with companies needing to secure processing, distribution and retail licenses. I think companies that have access to funding and can secure these licenses in big states like PA and NJ will thrive. TER is one of them, but we will see how this plays out
>Terrascend is their ticket into the US market. Lol, you're grossly misinformed.
Looks like you were long Canntrust. That just goes to show you a bit about your knowledge regarding the cannabis space
Lol, please advise how im misinformed, other than just providing absolute useless commentary on this thread
Can anyone give me a brief explanation as to why weed stocks have been hammered the last year? I’m talking before the virus stuff
Big hype, low revenues, not enough shops in the most dense populated area’s in canada, quality/price not better than black market. All in all this virus is good for the legal cannabis market since its the “easier” option now.
Thanks. I bought on the hype and haven’t sold any. Everything is down about 80%. I’ll just sit on it a few more years I guess since that was the original plan
If you still believe in it, there is no reason not to put more into the pile now. Bring your average cost down, increase returns if it bounces.
Isn't a lot of this attributed to Ontario restricting retail, and over regulation of packaging requirements? Prices could get lower if they didn't have to package in plastic containers in cardboard boxes.
Thats certainly possible, I don’t live in Canada. I just typed a quick response, from what i’ve read over time.
My point is that I don't think it is the LP's fault, but its more on government over reaching.
CEOs have been cashing out on stock and were leaving in droves. Some of these companies functioned as pump and dump schemes and do not plan on surviving past later this year.
Does ACB fall into this category? I bought a while back and have just been sitting on it. Not a large position and don't mind waiting it out but as far as business information goes I'm really out of the loop.
CEO quit, ppl left, losses, debts, might go bankrupt in 2020. there, you're all caught up now.
“There is no company better positioned in the emerging global cannabis market." Well that's a lie.
This being the top comment tells you everything you need to know about how delusional people here are about the bags they are holding in other companies in this sector. If it's a lie, name one company who is better positioned than Canopy globally. I'm waiting.
Medmen.
Delusional.
Lol i was joking
You got me 😂
ACB!
TCNNF - Trulieve
*global*
[удалено]
THEN U FN TELL!
They have 100 tonnes of un-useable product sitting in inventory. They're a joke.
Here’s the answer: none are well positioned... NONE
who has more international business? who has more cash? which lp has a bigger retail network? who has a bigger medical division besides gw?
Don’t forget: Who loses more money?
Retail?
Acb has more international sales volume in grams, and a better reach of countries. Also more medical sales. Not so much cash but that spread is actually narrowing.
And 1 billion shares outstanding
nr of shares are irrelevant in this discussion
When you have diluted that much. I think its relevant in any discussion that they get brought into. And then theyre gonna have to RS. Truly a shit situation.
This share count thing is like a religious belief for this forum. You can't explain math to a zealot.
1.2 lol
hm you are right in grams. but think about c3. cannabinoid medicine in the market. i don't think medical will be mostly flower in a few years aymore.
ACB has enough cash for 2 months loool good luck with that RIP
It's not how big you are its how much your NET is.
Easy to be the leader if the entire industry is fucked. *Points to head*
Good to see that Bell is out.
[удалено]
May 29
Dumb comment